• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用定量气雾剂的支气管哮喘皮质激素疗法]

[Corticotherapy of bronchial asthma, using dosed aerosols].

作者信息

Popescu C, Basacopol A

出版信息

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1981 Oct-Dec;30(4):225-30.

PMID:6278565
Abstract

Corticoid therapy with dosed aerosols is one of the achievements that have been made lately in the treatment of bronchial asthma. In view of establishing the efficiency of this type of treatment two preparations have been used: Auxiloson (isonicotinate of dexamethasone), and Becotide (dipropionate of belcomethasone), in two groups of patients. The favourable results obtained involved over 80% of the patients treated with each of these drugs. The use of corticoid therapy with dosed aerosols in the treatment of bronchial asthma reduces many of the risks of the general therapy with corticoids, and is indicated in the maintenance therapy of patients, between asthma attacks, in the intervals when the risk of such attacks is increased, and especially in the long term treatment of corticoid-dependent bronchial asthma.

摘要

使用定量气雾剂进行皮质激素治疗是近年来支气管哮喘治疗方面取得的成就之一。为确定这种治疗方式的有效性,在两组患者中使用了两种制剂:奥索米松(地塞米松异烟酸盐)和必可酮(倍氯米松二丙酸酯)。使用这两种药物治疗的患者中,超过80%取得了良好效果。在支气管哮喘治疗中,使用定量气雾剂进行皮质激素治疗可降低皮质激素全身治疗的许多风险,适用于哮喘发作间歇期、发作风险增加期患者的维持治疗,尤其适用于皮质激素依赖型支气管哮喘的长期治疗。

相似文献

1
[Corticotherapy of bronchial asthma, using dosed aerosols].[使用定量气雾剂的支气管哮喘皮质激素疗法]
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1981 Oct-Dec;30(4):225-30.
2
[Steroid aerosols in asthma. Comparative simple blind study of beclomethasone dipropionate and dexamethasone isonicotinate].
Nouv Presse Med. 1977 Apr 13;6(15):1297-9.
3
Therapeutic index of steroid aerosols in asthma. A single-blind comparative trial of beclomethasone dipropionate vs dexamethasone isonicotinate.哮喘中类固醇气雾剂的治疗指数。丙酸倍氯米松与异烟腙地塞米松的单盲对比试验。
Acta Allergol. 1975 Dec;30(6):363-74.
4
[Supplementation of long-term corticoid therapy by beclomethasone dipropionate (DPB)].
Nouv Presse Med. 1977 Apr 13;6(15):1293-4.
5
[Defining the position of steroid aerosol in the treatment of bronchial asthma--studies of steroid withdrawal methods with beclomethasone dipropionate inhaler].[确定类固醇气雾剂在支气管哮喘治疗中的地位——丙酸倍氯米松吸入器的类固醇撤药方法研究]
Nihon Kyobu Shikkan Gakkai Zasshi. 1985 Feb;23(2):188-98.
6
[Long-term results of aerosol treatment of subjects with asthma and spastic bronchitis with dexamethasone isonicotinate (author's transl)].地塞米松异烟酸盐雾化治疗哮喘和痉挛性支气管炎患者的长期结果(作者译)
Acta Tuberc Pneumol Belg. 1977 Jan-Mar;68(1):53-62.
7
Beclomethasone dipropionate aerosol: a substitute for systemic corticosteroid treatment in bronchial asthma.
Postgrad Med J. 1975;51 Suppl 4:70-1.
8
[Bronchoselective beta stimulators and corticoid aerosols in the treatment of asthma].支气管选择性β受体激动剂和皮质类固醇气雾剂治疗哮喘
Z Gesamte Inn Med. 1979 Apr 1;34(7):65-7.
9
[Trial of a corticoid (HE 111) aerosol doser in the treatment of obstructive respiratory diseases].[皮质激素(HE 111)气雾剂治疗阻塞性呼吸道疾病的试验]
Acta Tuberc Pneumol Belg. 1974 Sep-Oct;65(5):540-51.
10
[Longtime corticoid therapy of asthma without risk?].[长期使用皮质类固醇治疗哮喘无风险?]
Dtsch Med Wochenschr. 1980 Sep 26;105(39):1329-32. doi: 10.1055/s-2008-1070865.